Six vulnerabilities in the widely used U-Boot bootloader have been discovered that could allow attackers to execute malicious ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
With Sidewinder, Ares graduated from a scanner that followed a script to an adversary that thinks. Where Dagger marched every target through the same fixed sequence of phases on a single fine-tuned ...
Vitalik Buterin outlined the updated Lean Ethereum roadmap, a 3-to-4-year plan covering quantum resistance, 10,000 TPS ...
On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...
It's an upgrade worth making, but it comes down to your privacy concerns.
New VentureBeat survey data: 85% of enterprises run contested AI platforms with no single owner, and only 10% can ...
As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...
What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...
12d
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results